Nasacort Allergy nasal spray switched from P to GSL as of May

The MHRA has approved the application to reclassify Nasacort Allergy 55 micrograms/dose nasal spray from a pharmacy (P) medicine to general sales list (GSL) item.

Nasacort.jpg
MHRA: The increased availability of another nasal steroid spray would be useful to individuals

Latest from News

More from Clinical